The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Antibiotic resistance in Burkholderia species
Open accessAbstract
The genus Burkholderia comprises metabolically diverse and adaptable Gram-negative bacteria, which thrive in often adversarial environments. A few members of the genus are prominent opportunistic pathogens. These include B. mallei and B. pseudomallei of the B. pseudomallei complex, which cause glanders and melioidosis, respectively. B. cenocepacia, B. multivorans, and B. vietnamiensis belong to the B. cepacia complex and affect mostly cystic fibrosis patients. Infections caused by these bacteria are difficult to treat because of significant antibiotic resistance. The first line of defense against antimicrobials in Burkholderia species is the outer membrane penetration barrier. Most Burkholderia contain a modified lipopolysaccharide that causes intrinsic polymyxin resistance. Contributing to reduced drug penetration are restrictive porin proteins. Efflux pumps of the resistance nodulation cell division family are major players in Burkholderia multidrug resistance. Third and fourth generation β-lactam antibiotics are seminal for treatment of Burkholderia infections, but therapeutic efficacy is compromised by expression of several β-lactamases and ceftazidime target mutations. Altered DNA gyrase and dihydrofolate reductase targets cause fluoroquinolone and trimethoprim resistance, respectively. Although antibiotic resistance hampers therapy of Burkholderia infections, the characterization of resistance mechanisms lags behind other non-enteric Gram-negative pathogens, especially ESKAPE bacteria such as Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Molecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092
Antibacterial drug discovery in the resistance era
Brown, E. D., & Wright, G. D. (2016) · Nature · doi:10.1038/nature17042 · Cited by 2,247
Melioidosis: Epidemiology, Pathophysiology, and Management
Cheng, A. C., & Currie, B. J. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.383-416.2005 · Cited by 1,464
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Olaitan, A. O., Morand, S., & Rolain, J.-M. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00643 · Cited by 1,395
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231 · cited 1×
“218 Bacterial genomes encode at least six efflux pump families (Fernandez and Hancock, 219 2012ß; Hassan et al., 2015; Nikaido and Pages, 2012; Piddock, 2006).”
BackgroundA standard numbering scheme for the class A β-lactamases
Ambler, R. P., Coulson, A. F. W., Frère, J. M., Ghuysen, J. M., Joris, B., Forsman, M., Levesque, R. C., Tiraby, G., & Waley, S. G. (1991) · Biochemical Journal · doi:10.1042/bj2760269 · Cited by 1,073
The Antimicrobial Resistance Crisis: Causes, Consequences, and Management
Michael, C. A., Dominey-Howes, D., & Labbate, M. (2014) · Frontiers in Public Health · doi:10.3389/fpubh.2014.00145 · Cited by 974
The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria
Pagès, J.-M., James, C. E., & Winterhalter, M. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1994 · Cited by 939
Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance
Fernández, L., & Hancock, R. E. W. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00043-12 · Cited by 892
The multifarious, multireplicon Burkholderia cepacia complex
Mahenthiralingam, E., Urban, T. A., & Goldberg, J. B. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1085 · Cited by 876
Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L. M., & Nakamura, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.8.1647 · Cited by 777
Currie, B. J., Ward, L., & Cheng, A. C. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000900 · Cited by 771
Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria
Nikaido, H., & Pagès, J.-M. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00290.x · Cited by 769
Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei
Holden, M. T. G., Titball, R. W., Peacock, S. J., Cerdeño-Tárraga, A. M., Atkins, T., Crossman, L. C., Pitt, T., Churcher, C., Mungall, K., Bentley, S. D., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403302101 · Cited by 758
Wiersinga, W. J., Currie, B. J., & Peacock, S. J. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1204699 · Cited by 716
Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei
Wiersinga, W. J., van der Poll, T., White, N. J., Day, N. P., & Peacock, S. J. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1385 · Cited by 585
Resistance Mechanisms in Pseudomonas aeruginosa and Other Nonfermentative Gram‐Negative Bacteria
Hancock, R. E. W. (1998) · Clinical Infectious Diseases · doi:10.1086/514909 · Cited by 583
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., & Nakamura, S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1271 · Cited by 570
Biofilm-Specific Antibiotic Resistance
Mah, T.-F. (2012) · Future Microbiology · doi:10.2217/fmb.12.76 · Cited by 504
Sawana, A., Adeolu, M., & Gupta, R. S. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00429 · Cited by 492
Structural flexibility in the Burkholderia mallei genome
Nierman, W. C., DeShazer, D., Kim, H. S., Tettelin, H., Nelson, K. E., Feldblyum, T., Ulrich, R. L., Ronning, C. M., Brinkac, L. M., Daugherty, S. C., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403306101 · Cited by 395
The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients
Holden, M. T. G., Seth-Smith, H. M. B., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeño-Tárraga, A. M., Thomson, N. R., Bason, N., Quail, M. A., Sharp, S., et al. (2009) · Journal of Bacteriology · doi:10.1128/jb.01230-08 · Cited by 340
Studies on the nonmevalonate terpene biosynthetic pathway: Metabolic role of IspH (LytB) protein
Rohdich, F., Hecht, S., Gärtner, K., Adam, P., Krieger, C., Amslinger, S., Arigoni, D., Bacher, A., & Eisenreich, W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032658999 · Cited by 338
Vanlaere, E., Baldwin, A., Gevers, D., Henry, D., De Brandt, E., LiPuma, J. J., Mahenthiralingam, E., Speert, D. P., Dowson, C., & Vandamme, P. (2009) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijs.0.001123-0 · Cited by 321
Efflux-Mediated Aminoglycoside and Macrolide Resistance in Burkholderia pseudomallei
Moore, R. A., DeShazer, D., Reckseidler, S., Weissman, A., & Woods, D. E. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.465 · Cited by 305
Looking for Chinks in the Armor of Bacterial Biofilms
Monroe, D. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050307 · Cited by 300
A problem of persistence: still more questions than answers?
Balaban, N. Q., Gerdes, K., Lewis, K., & McKinney, J. D. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3076 · Cited by 263
Schweizer, H. P. (2012) · Future Microbiology · doi:10.2217/fmb.12.116 · Cited by 259
Self-citationThe Burkholderia Genome Database: facilitating flexible queries and comparative analyses
Winsor, G. L., Khaira, B., Van Rossum, T., Lo, R., Whiteside, M. D., & Brinkman, F. S. L. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn524 · Cited by 243
Molecular Insights into Burkholderia pseudomallei and Burkholderia mallei Pathogenesis
Galyov, E. E., Brett, P. J., & DeShazer, D. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134030 · Cited by 243
Antibiotic Resistance: A Public Health Crisis
Lushniak, B. D. (2014) · Public Health Reports® · doi:10.1177/003335491412900402 · Cited by 216
Classification and identification of the Burkholderia cepacia complex: Past, present and future
Vandamme, P., & Dawyndt, P. (2011) · Systematic and Applied Microbiology · doi:10.1016/j.syapm.2010.10.002 · Cited by 184
Hassan, K. A., Liu, Q., Henderson, P. J. F., & Paulsen, I. T. (2015) · mBio · doi:10.1128/mbio.01982-14 · Cited by 181
Glanders: an overview of infection in humans
Zandt, K. E. V., Greer, M., & Gelhaus, H. C. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-131 · Cited by 178
Management of Accidental Laboratory Exposure to Burkholderia pseudomallei and B. mallei
Peacock, S. J., Schweizer, H. P., Dance, D. A. B., Smith, T. L., Gee, J. E., Wuthiekanun, V., DeShazer, D., Steinmetz, I., Tan, P., & Currie, B. J. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1407.071501 · Cited by 174
Self-citationYu, Y., Kim, H. S., Chua, H. H., Lin, C. H., Sim, S. H., Lin, D., Derr, A. G., Engels, R., DeShazer, D., Birren, B. W., et al. (2006) · BMC Microbiology · doi:10.1186/1471-2180-6-46 · Cited by 159
Glanders: off to the races with Burkholderia mallei
Whitlock, G. C., Estes, D. M., & Torres, A. G. (2007) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2007.00949.x · Cited by 154
Efflux pump-mediated drug resistance in Burkholderia
Podnecky, N. L., Rhodes, K. A., & Schweizer, H. P. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00305 · Cited by 143
Self-citationChan, Y. Y., & Chua, K. L. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.14.4707-4719.2005 · Cited by 136
Evolution of Burkholderia pseudomallei in Recurrent Melioidosis
Hayden, H. S., Lim, R., Brittnacher, M., Sims, E. H., Ramage, E. R., Fong, C. T., Wu, Z., Crist, E. M., Chang, J., Zhou, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036507 · Cited by 128
Wuthiekanun, V., & Peacock, S. J. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.3.445 · Cited by 122
Intravenous Therapy Duration and Outcomes in Melioidosis: A New Treatment Paradigm
Pitman, M. C., Luck, T., Marshall, C., Anstey, N. M., Ward, L. M., & Currie, B. J. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003586 · Cited by 121
Zhou, J. J., Chen, Y., Tabibi, S., Alba, L., Garber, E., & Saiman, L. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00954-06 · Cited by 118
Chantratita, N., Rholl, D. A., Sim, B., Wuthiekanun, V., Limmathurotsakul, D., Amornchai, P., Thanwisai, A., Chua, H. H., Ooi, W. F., Holden, M. T. G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111020108 · Cited by 117
Self-citationExtreme Antimicrobial Peptide and Polymyxin B Resistance in the Genus Burkholderia
Loutet, S. A., & Valvano, M. A. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00159 · Cited by 116
BpeAB-OprB, a Multidrug Efflux Pump in Burkholderia pseudomallei
Chan, Y. Y., Tan, T. M. C., Ong, Y. M., & Chua, K.-L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1128-1135.2004 · Cited by 116
The Early Stage of Bacterial Genome-Reductive Evolution in the Host
Song, H., Hwang, J., Yi, H., Ulrich, R. L., Yu, Y., Nierman, W. C., & Kim, H. S. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000922 · Cited by 113
Continuing Evolution of Burkholderia mallei Through Genome Reduction and Large-Scale Rearrangements
Losada, L. C., Ronning, C. M., DeShazer, D., Woods, D. E., Fedorova, N. D., Kim, H. S., Shabalina, S. A., Pearson, T., Brinkac, L. M., Tan, P. B. O., et al. (2010) · Genome Biology and Evolution · doi:10.1093/gbe/evq003 · Cited by 113
Mima, T., & Schweizer, H. P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01803-09 · Cited by 109
Self-citationDeciphering the Role of RND Efflux Transporters in Burkholderia cenocepacia
Bazzini, S., Udine, C., Sass, A. M., Pasca, M. R., Longo, F., Emiliani, G., Fondi, M., Perrin, E., Decorosi, F., Viti, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018902 · Cited by 106
Tribuddharat, C., Moore, R. A., Baker, P. L., & Woods, D. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2082-2087.2003 · Cited by 105
Sarovich, D. S., Price, E. P., Schulze, A. T. V., Cook, J. M., Mayo, M. J., Watson, L. M., Richardson, L. J., Seymour, M. L., Tuanyok, A., Engelthaler, D. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030789 · Cited by 103
Peeters, E., Nelis, H. J., & Coenye, T. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp253 · Cited by 96
Nair, B. M., Cheung, K. J., Griffith, A., & Burns, J. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19710 · Cited by 95
Kumar, A., Chua, K.-L., & Schweizer, H. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00440-06 · Cited by 90
Self-citationVadlamani, G., Thomas, M. D., Patel, T. R., Donald, L. J., Reeve, T. M., Stetefeld, J., Standing, K. G., Vocadlo, D. J., & Mark, B. L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.618199 · Cited by 88
Molecular Investigations of PenA-mediated β-lactam Resistance in Burkholderia pseudomallei
Rholl, D. A., Papp‐Wallace, K. M., Tomaras, A. P., Vasil, M. L., Bonomo, R. A., & Schweizer, H. P. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00139 · Cited by 84
Self-citationJohn, J. A. S., Ekberg, J. A. K., Dando, S. J., Meedeniya, A. C. B., Horton, R. E., Batzloff, M. R., Owen, S., Holt, S., Peak, I. R. A., Ulett, G. C., et al. (2014) · mBio · doi:10.1128/mbio.00025-14 · Cited by 83
Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia
Parr, T. R., Moore, R. A., Moore, L. V., & Hancock, R. E. W. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.1.121 · Cited by 81
Novem, V., Shui, G., Wang, D., Bendt, A. K., Sim, S. H., Liu, Y., Thong, T. W., Sivalingam, S. P., Ooi, E. E., Wenk, M. R., et al. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00472-08 · Cited by 81
Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection
Sarovich, D. S., Price, E. P., Peacock, S. J., Cook, Vonschulze, Wolken, Keim, Pearson, T., & Limmathurotsakul, D. (2012) · Infection and Drug Resistance · doi:10.2147/idr.s35529 · Cited by 73
Kenny, D. J., Russell, P., Rogers, D., Eley, S. M., & Titball, R. W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2773 · Cited by 73
Aronoff, S. C. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.11.1636 · Cited by 72
Nair, B. M., Cheung, K. J., Griffith, A., & Burns, J. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419710 · Cited by 72
Malott, R. J., Steen, B. R., Lee, T. D., & Speert, D. P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00602-11 · Cited by 62
Naturally Occurring Class A ß-Lactamases from the Burkholderia cepacia Complex
Poirel, L., Rodríguez-Martínez, J. M., Plésiat, P., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00946-08 · Cited by 59
Podnecky, N. L., Wuthiekanun, V., Peacock, S. J., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00660-13 · Cited by 58
Papp‐Wallace, K. M., Taracila, M. A., Gatta, J. A., Ohuchi, N., Bonomo, R. A., & Nukaga, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.458315 · Cited by 57
Buroni, S., Matthijs, N., Spadaro, F., Acker, H. V., Scoffone, V. C., Pasca, M. R., Riccardi, G., & Coenye, T. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03800-14 · Cited by 56
Biot, F., Valade, E., Garnotel, É., Chevalier, J., Villard, C., Thibault, F., Vidal, D. R., & Pagès, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016892 · Cited by 46
In Vitro Susceptibility of Burkholderia vietnamiensis to Aminoglycosides
Jassem, A. N., Zlosnik, J. E. A., Henry, D. A., Hancock, R. E. W., Ernst, R. K., & Speert, D. P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01434-10 · Cited by 39
Yi, H., Cho, K.-H., Cho, Y. S., Kim, K., Nierman, W. C., & Kim, H. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037585 · Cited by 37
Porin Involvement in Cephalosporin and Carbapenem Resistance of Burkholderia pseudomallei
Aunkham, A., Schulte, A., Winterhalter, M., & Suginta, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095918 · Cited by 29
Efflux pumps may play a role in tigecycline resistance in Burkholderia species
Rajendran, R., Quinn, R. F., Murray, C. A., McCulloch, E., Williams, C., & Ramage, G. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.03.009 · Cited by 29
Siritapetawee, J., Prinz, H., Krittanai, C., & Suginta, W. (2004) · Biochemical Journal · doi:10.1042/bj20041102 · Cited by 28
Jassem, A. N., Forbes, C. M., & Speert, D. P. (2014) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-13-2 · Cited by 20
Schweizer, H. P. (2012) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2012.00334.x · Cited by 18
Self-citationSpinal cord disease due to melioidosis
Bartley, P. B., Pender, M. P., Woods, M. L., Walker, D., Douglas, J. A., Allworth, A. M., Eisen, D. P., & Currie, B. J. (1999) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(99)90299-7 · Cited by 14
Suginta, W., Mahendran, K. R., Chumjan, W., Hajjar, E., Schulte, A., Winterhalter, M., & Weingart, H. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.10.018 · Cited by 14
Relapsing neurological melioidosis from the Top End of the Northern Territory
Maguire, G. P., Flavell, H. D., Burrow, J. N., & Currie, B. J. (1998) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1998.tb02978.x · Cited by 6
Cited by
Chaturvedi, P., Shukla, P., Giri, B. S., Chowdhary, P., Chandra, R., Gupta, P., & Pandey, A. (2021) · Environmental Research · doi:10.1016/j.envres.2020.110664 · Cited by 709
(BIOHAZ), E. P. O. B. H., Koutsoumanis, K., Allende, A., Alvarez‐Ordóñez, A., Bolton, D., Bover‐Cid, S., Chemaly, M., Davies, R., De Cesare, A., Hilbert, F., et al. (2021) · EFSA Journal · doi:10.2903/j.efsa.2021.6377 · Cited by 445
Daccò, V., Claut, L., Piconi, S., Castellazzi, L., Garbarino, F., Teri, A., & Colombo, C. (2019) · Transplant Infectious Disease · doi:10.1111/tid.13082 · Cited by 28
Hogan, A. M., Rahman, A. S. M. Z., Motnenko, A., Natarajan, A., Maydaniuk, D. T., León, B., Batun, Z., Palacios, A., Bosch, A., & Cardona, S. T. (2023) · Nature Communications · doi:10.1038/s41467-023-40494-5 · Cited by 16
Hogan, A. M., Natarajan, A., Maydaniuk, D. T., Léon, B., Batun, Z., Motnenko, A., Palacios, A., Bosch, A., & Cardona, S. T. (2022) · doi:10.1101/2022.11.01.510852 · Cited by 1
Metadata
- Authors
- Rhodes, K. A., & Schweizer, H. P.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 28
- Pages
- 82-90
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W2489287057
- Cited by
- 405
- References
- 81
- FWCI
- 21.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.